Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

Aim COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe
cases. While there are a number of early publications relating to risk factors for COVID-19 …

Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and
can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) …

Introduction: Although severe acute respiratory syndrome coronavirus-2 infection is causing
mortality in considerable proportion of coronavirus disease-2019 (COVID-19) patients …

Background To explore and describe the current literature surrounding bacterial/fungal
coinfection in patients with coronavirus infection. Methods MEDLINE, EMBASE, and Web of …

In an effort to mitigate the outbreak of COVID-19, many countries have imposed drastic
lockdown, movement control or shelter in place orders on their residents. The effectiveness …

Background Many studies on COVID-19 have reported diabetes to be associated with
severe disease and mortality, however, the data is conflicting. The objectives of this meta …

Background: Patients critically ill with coronavirus disease-2019 (COVID-19) feature
hyperinflammation, and the associated biomarkers may be beneficial for risk stratification …

Mortality rates of coronavirus disease‐2019 (COVID‐19) continue to rise across the world.
Information regarding the predictors of mortality in patients with COVID‐19 remains scarce …

Background Hydroxychloroquine and chloroquine have been proposed as treatments for
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …